" /> Mosunetuzumab/Polatuzumab Vedotin Regimen - CISMeF





Preferred Label : Mosunetuzumab/Polatuzumab Vedotin Regimen;

NCIt synonyms : Mosunetuzumab Plus Polatuzumab Vedotin-piiq; Mosunetuzumab-axgb/Polatuzumab Vedotin-piiq; Polivy/Lunsumio; Mosunetuzumab Plus Polatuzumab Vedotin; Lunsumio/Polivy Regimen; Mosunetuzumab/Polatuzumab Vedotin; Polatuzumab Vedotin/Mosunetuzumab; Polatuzumab Vedotin-piiq/Mosunetuzumab-axgb; Mosunetuzumab-Polatuzumab Vedotin;

NCIt definition : A regimen consisting of mosunetuzumab and polatuzumab vedotin that may be used in the treatment of diffuse large B-cell lymphoma (DLBCL).;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
08/09/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.